Fundz

Cytotrait raises £3M in seed funding led by Northern Gritstone to develop its proprietary MOSS technology for enhanced traits in major crop species.

PRIVATEMar 09, 2026

Amount Raised

£3 Million

Round Type

Seed

BiotechnologyAgriculture and Farming

Investors

UK Innovation & Science Seed FundNorthern Universities Ventures FundNorthern Gritstone

Description

Cytotrait, a biotechnology company based in Manchester, UK, has closed a £3M seed funding round. The funding will support the development of novel traits for food and agriculture using their Mutant Organelle Selection System (MOSS). Led by Northern Gritstone, the round also saw contributions from UKI2S and Northern Universities Ventures Fund. The company aims to enhance crop species with substantial commercial opportunities.

Quick answer

Cytotrait raised £3 Million in a Seed round, dated March 9, 2026. Investors: UK Innovation & Science Seed Fund, Northern Universities Ventures Fund and Northern Gritstone.

How much did Cytotrait raise?
Cytotrait raised £3 Million in a Seed round on March 9, 2026.
Who invested in Cytotrait?
UK Innovation & Science Seed Fund, Northern Universities Ventures Fund and Northern Gritstone are named as investors in this round.
What does Cytotrait do?
Cytotrait is a biotechnology company based in Manchester, UK, focused on developing novel traits for food and agriculture.
Where is Cytotrait based and how big is it?
Fundz records about 6 employees.

Source: Fundz verified event record.

Who else raised in Agriculture and Farming and Biotechnology around the same time

Companies in the same sectors as Cytotrait that raised within 45 days of this round, from Fundz verified event records.

  • Agriodor raised $18M (Series A) on April 15, 2026.
  • Mountain Valley MD raised $1.2M on April 14, 2026.
  • AquaBounty raised $4.8M on April 7, 2026.
  • Elmed Life Sciences raised $2.7M (Seed) on March 26, 2026.
  • Cauldron raised $13M (Series A) on March 24, 2026.
  • Verility raised $150K (Seed) on March 9, 2026.

Who to call at Cytotrait, and when

A new round usually means Cytotrait is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cytotrait raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cytotrait, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cytotrait. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cytotrait

About

Cytotrait is a biotechnology company based in Manchester, UK, focused on developing novel traits for food and agriculture. Their proprietary technology, the Mutant Organelle Selection System (MOSS), enables the introduction of genes and gene edits into organelles to generate homoplasmy. This approach allows the engineering of traits with high-level expression and promises increased yield, pest resistance, and improved crop development. The company aims to leverage its technology for substantial commercial opportunities in the agricultural sector.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cytotrait raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Cytotrait's next move

See what Strategic adds

Cytotrait raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.